Results 261 to 270 of about 549,379 (280)

Concurrent chemoradiotherapy with S-1 and cisplatin in advanced esophageal cancer

Diseases of the Esophagus, 2008
How best to manage advanced esophageal cancer remains unresolved, especially in palliative care. Here, in a pilot study, we evaluated the efficacy and safety of concurrent chemoradiotherapy with S-1 and cisplatin in advanced esophageal cancer. Patients with locally advanced or metastatic squamous cell carcinoma of the esophagus received S-1 and ...
Taek-Keun Nam, Hak Jun Kim, D.-H. Yang, Jae-Sook Ahn, Y.-K. Kim, J. J. Lee, Ik Joo Chung, Hyun-Jeong Shim, Se-Ryeon Lee, Sung-Bum Cho   +9 more
openaire   +3 more sources

Concurrent chemoradiotherapy with paclitaxel and cisplatin for adenocarcinoma of the cervix.

Journal of Clinical Oncology, 2012
5086 Background: Adenocarcinoma of the cervix has a worse prognosis than its squamous counterpart, particularly when cancer cells spread beyond the uterine cervix. This is derived from the observation that adenocarcinoma is less sensitive to radiotherapy (RT) and chemotherapy It is unclear whether cisplatin-based concurrent chemoradiotherapy (CCRT ...
Morihiko Inamine, Yutaka Nagai, Yoichi Aoki, Akihiko Wakayama, Akemi Tokura, Takafumi Toita, Takuma Ooyama, Wataru Kudaka, Tomoko Nakamoto   +8 more
openaire   +2 more sources

Concurrent chemoradiotherapy for primary cervical spinal cord germinoma

Journal of Clinical Neuroscience, 2009
We report a rare case of primary intramedullary germinoma in the cervical spine of a 39-year-old woman without evidence of intracranial or disseminated disease. The germinoma was treated by a biopsy and follow-up concurrent chemoradiotherapy. This is the only reported case of primary spinal cord germinoma for which concurrent chemoradiotherapy was ...
Jih-Tsun Ho, Ka-Yen Yang, Shau-Hsuan Li, Thung-Ming Su, Wu-Fu Chen, Jui-Wei Lin   +5 more
openaire   +2 more sources

Patient and Treatment Factors in Concurrent Chemoradiotherapy

2016
The MACH-NC analysis demonstrated a 6.5 % absolute improvement in 5-year overall survival with concurrent chemoradiotherapy (CCRT) over radiotherapy (RT) alone. High-dose cisplatin (100 mg/m2 on days 1, 22, and 43 during RT) was identified as the most effective regimen.
openaire   +2 more sources

The change in circulating tumor cells before and during concurrent chemoradiotherapy is associated with survival in patients with locally advanced head and neck cancer

Head and Neck, 2019
This study aimed to evaluate the role of baseline circulating tumor cells (CTCs) before and during concurrent chemoradiotherapy and attempted to determine the impacts of CTCs on the outcomes in patients with head and neck squamous cell carcinoma.
Hung-Ming Wang, Min-Hsien Wu, Pei-Hung Chang, Hung-Chi Lin, Chunyao Liao, Shengchao Wu, T. Hung, Chine-Yu Lin, T. Chang, Yen Tzu-Tsen, J. Hsieh   +10 more
semanticscholar   +1 more source

Concurrent chemoradiotherapy in non-small cell lung cancer

Cochrane Database of Systematic Reviews, 2010
This is an updated version of the original review published in Issue 4, 2004. The use of concurrent chemotherapy and radiotherapy in non-small cell lung cancer (NSCLC) might be seen as a way of increasing the effectiveness of radical radiotherapy at the same time as reducing the risks of metastatic disease.To determine the effectiveness of concurrent ...
Fergus Macbeth, Nuria Farré Bernadó, Noelle O'Rourke, Marta Roqué i Figuls   +3 more
openaire   +3 more sources

Concurrent Chemoradiotherapy in the Treatment of Locally Recurrent Rectal Cancer

Hepatogastroenterology, 2012
Long course concurrent chemoradiotherapy provides potential tumor downstaging. When local recurrent rectal cancer without distant metastases is diagnosed, a potentially curative resection can be performed. The aim of this study was to assess the outcome of concurrent chemoradiotherapy in treating isolated local recurrent rectal cancer.Patients (n=102 ...
Reiping Tang, Sum-Fu Chiang, Hsin-Yuan Hung, Pao-Shiu Hsieh, Jy-Ming Chiang, Jinn-Shiun Chen, Chien-Yuh Yeh, Chung-Rong Changchien, Yau-Tong You, Wen-Sy Tasi, Jeng-Fu You, Jeng-Yi Wang   +11 more
openaire   +2 more sources

Evaluation of oral tegafur‐uracil as metronomic therapy following concurrent chemoradiotherapy in patients with non‐distant metastatic TNM stage IV nasopharyngeal carcinoma

Head and Neck, 2019
The study was aimed to evaluate the impact of accumulated oral tegafur‐uracil (UFUR) as maintenance chemotherapy on overall survival (OS) and disease‐free survival (DFS) rates after concurrent chemoradiotherapy (CCRT) for complete remission (CR) in non ...
Jia-Hong Chen, Wen-Yen Huang, C. Ho, T. Chao, Jih-Chin Lee   +4 more
semanticscholar   +1 more source

Neoadjuvant chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone on locally advanced nasopharyngeal carcinoma

JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020
C Jiang, X R Ding, H X Hui, H Liu, X M Zhong, Y Q Song   +5 more
openaire   +3 more sources

Concurrent chemoradiotherapy is not the only answer

Clinical Otolaryngology, 2007
Birchall Ma, D.G. Grant
openaire   +3 more sources